| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 4.39e-09 | 4 | 164 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 4.39e-09 | 4 | 164 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 2.18e-08 | 5 | 164 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.51e-07 | 7 | 164 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 3.23e-07 | 55 | 164 | 7 | GO:0008146 | |
| GeneOntologyMolecularFunction | sulfate binding | 5.35e-07 | 9 | 164 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 8.86e-07 | 10 | 164 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 2.16e-06 | 4 | 164 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 2.16e-06 | 4 | 164 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 2.51e-06 | 74 | 164 | 7 | GO:0016782 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 2.96e-06 | 13 | 164 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 2.00e-04 | 3 | 164 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.30e-04 | 15 | 164 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 6.60e-04 | 5 | 164 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.60e-04 | 5 | 164 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 1.16e-03 | 56 | 164 | 4 | GO:0016763 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.87e-08 | 5 | 163 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | sulfation | 2.03e-06 | 27 | 163 | 5 | GO:0051923 | |
| GeneOntologyBiologicalProcess | cilium organization | GBF1 SYNE1 CNTRL RTTN LAMA5 ALPK1 ODF2 EHD2 DNAAF5 BBS7 SYNE2 CEP83 PKHD1 DNMBP DNAH8 | 5.94e-06 | 476 | 163 | 15 | GO:0044782 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 8.26e-06 | 17 | 163 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 8.26e-06 | 17 | 163 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 8.26e-06 | 17 | 163 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.06e-05 | 18 | 163 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | cilium assembly | GBF1 SYNE1 CNTRL LAMA5 ALPK1 ODF2 EHD2 DNAAF5 BBS7 SYNE2 CEP83 PKHD1 DNMBP DNAH8 | 1.22e-05 | 444 | 163 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 2.64e-05 | 8 | 163 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.96e-05 | 23 | 163 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | cell projection assembly | GBF1 SYNE1 CNTRL LAMA5 ALPK1 ODF2 MSTN CYFIP2 EHD2 DNAAF5 BBS7 CLN3 SYNE2 CEP83 PKHD1 DNMBP DNAH8 | 3.14e-05 | 685 | 163 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 GBF1 NOP53 SYNE1 CNTRL RTTN LAMA5 ALPK1 ODF2 EHD2 ULK3 DNAAF5 NPTXR BBS7 CLN3 HPS4 SYNE2 CEP83 PKHD1 TMEM41B DNMBP DNAH8 MYBPC1 | 3.21e-05 | 1138 | 163 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 7.63e-05 | 11 | 163 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | GBF1 SYNE1 CNTRL LAMA5 ALPK1 ODF2 MSTN EHD2 DNAAF5 BBS7 CLN3 SYNE2 CEP83 PKHD1 DNMBP DNAH8 | 8.52e-05 | 670 | 163 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.31e-04 | 13 | 163 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | centrosome localization | 1.63e-04 | 35 | 163 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.82e-04 | 36 | 163 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.97e-04 | 106 | 163 | 6 | GO:0034308 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.82e-04 | 73 | 163 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 3.01e-04 | 74 | 163 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 3.01e-04 | 74 | 163 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 3.04e-04 | 17 | 163 | 3 | GO:0030202 | |
| MousePheno | enlarged gallbladder | 4.57e-06 | 28 | 126 | 5 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 9.10e-06 | 32 | 126 | 5 | MP:0020134 | |
| MousePheno | abnormal gallbladder morphology | 1.60e-05 | 60 | 126 | 6 | MP:0005084 | |
| MousePheno | impaired cranial neural crest cell differentiation | 8.06e-05 | 2 | 126 | 2 | MP:0012756 | |
| MousePheno | abnormal biliary tract morphology | 8.92e-05 | 117 | 126 | 7 | MP:0005083 | |
| Domain | ARM-type_fold | MON2 DOCK2 GBF1 COPB1 DOCK9 RTTN TSC2 WDFY4 LYST FOCAD DNAAF5 NCAPG IPO9 UNC45B ELMO2 XPO6 UTP20 UNC79 TANGO6 | 9.03e-11 | 339 | 159 | 19 | IPR016024 |
| Domain | Sulfotransfer_1 | 1.93e-08 | 36 | 159 | 7 | PF00685 | |
| Domain | Sulfotransferase_dom | 1.93e-08 | 36 | 159 | 7 | IPR000863 | |
| Domain | - | MON2 COPB1 RTTN TSC2 WDFY4 DNAAF5 NCAPG IPO9 UNC45B ELMO2 XPO6 UTP20 TANGO6 | 5.81e-08 | 222 | 159 | 13 | 1.25.10.10 |
| Domain | ARM-like | MON2 DOCK2 COPB1 RTTN TSC2 WDFY4 DNAAF5 NCAPG IPO9 UNC45B ELMO2 XPO6 UTP20 TANGO6 | 8.06e-08 | 270 | 159 | 14 | IPR011989 |
| Domain | Heparan_SO4_deacetylase | 2.41e-06 | 4 | 159 | 3 | IPR021930 | |
| Domain | HSNSD | 2.41e-06 | 4 | 159 | 3 | PF12062 | |
| Domain | MOZART2 | 7.20e-05 | 2 | 159 | 2 | IPR024332 | |
| Domain | - | 7.20e-05 | 2 | 159 | 2 | 1.25.40.170 | |
| Domain | MOZART2 | 7.20e-05 | 2 | 159 | 2 | PF12926 | |
| Domain | PHAT_dom | 7.20e-05 | 2 | 159 | 2 | IPR015327 | |
| Domain | KASH | 4.27e-04 | 4 | 159 | 2 | IPR012315 | |
| Domain | G8_domain | 4.27e-04 | 4 | 159 | 2 | IPR019316 | |
| Domain | KASH | 4.27e-04 | 4 | 159 | 2 | PS51049 | |
| Domain | G8 | 4.27e-04 | 4 | 159 | 2 | PS51484 | |
| Domain | KASH | 4.27e-04 | 4 | 159 | 2 | SM01249 | |
| Domain | G8 | 4.27e-04 | 4 | 159 | 2 | SM01225 | |
| Domain | KASH | 4.27e-04 | 4 | 159 | 2 | PF10541 | |
| Domain | G8 | 4.27e-04 | 4 | 159 | 2 | PF10162 | |
| Domain | Sec7_N | 4.27e-04 | 4 | 159 | 2 | IPR032691 | |
| Domain | Sec7_N | 4.27e-04 | 4 | 159 | 2 | PF12783 | |
| Domain | - | NDST1 NLRP12 TDRD9 ABCB5 NDST4 DDX56 EHD2 NDST3 SULT1A2 TRANK1 DNAH12 SULT1A1 DHX32 DNAH8 MPP7 NLRP13 | 6.42e-04 | 746 | 159 | 16 | 3.40.50.300 |
| Domain | SH3_2 | 8.39e-04 | 86 | 159 | 5 | PF07653 | |
| Domain | SH3_2 | 8.39e-04 | 86 | 159 | 5 | IPR011511 | |
| Domain | P-loop_NTPase | NDST1 MYH3 NLRP12 TDRD9 ABCB5 NDST4 DDX56 EHD2 NDST3 SULT1A2 TRANK1 DNAH12 SULT1A1 DHX32 DNAH8 MPP7 NLRP13 | 9.21e-04 | 848 | 159 | 17 | IPR027417 |
| Domain | PbH1 | 1.06e-03 | 6 | 159 | 2 | SM00710 | |
| Domain | PbH1 | 1.06e-03 | 6 | 159 | 2 | IPR006626 | |
| Domain | Pectin_lyase_fold/virulence | 1.95e-03 | 8 | 159 | 2 | IPR011050 | |
| Domain | PH-BEACH_dom | 1.95e-03 | 8 | 159 | 2 | IPR023362 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.95e-03 | 8 | 159 | 2 | PS51783 | |
| Domain | Leu-rich_rpt | 2.28e-03 | 271 | 159 | 8 | IPR001611 | |
| Domain | BEACH | 2.49e-03 | 9 | 159 | 2 | PS50197 | |
| Domain | Beach | 2.49e-03 | 9 | 159 | 2 | PF02138 | |
| Domain | - | 2.49e-03 | 9 | 159 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.49e-03 | 9 | 159 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.49e-03 | 9 | 159 | 2 | IPR000409 | |
| Domain | SPEC | 2.51e-03 | 32 | 159 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.51e-03 | 32 | 159 | 3 | IPR018159 | |
| Domain | HEAT_REPEAT | 3.00e-03 | 70 | 159 | 4 | PS50077 | |
| Domain | Glyco_transf_8 | 3.10e-03 | 10 | 159 | 2 | PF01501 | |
| Domain | Glyco_trans_8 | 3.10e-03 | 10 | 159 | 2 | IPR002495 | |
| Domain | DHR-1_domain | 3.77e-03 | 11 | 159 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.77e-03 | 11 | 159 | 2 | PS51651 | |
| Domain | DHR_1 | 3.77e-03 | 11 | 159 | 2 | PS51650 | |
| Domain | DHR-2 | 3.77e-03 | 11 | 159 | 2 | PF06920 | |
| Domain | DOCK | 3.77e-03 | 11 | 159 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.77e-03 | 11 | 159 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.77e-03 | 11 | 159 | 2 | PF14429 | |
| Domain | DHR-2 | 3.77e-03 | 11 | 159 | 2 | IPR027357 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.13e-03 | 14 | 159 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 6.13e-03 | 14 | 159 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.13e-03 | 14 | 159 | 2 | PF08393 | |
| Domain | IMPORTIN_B_NT | 6.13e-03 | 14 | 159 | 2 | PS50166 | |
| Domain | ATPase_dyneun-rel_AAA | 6.13e-03 | 14 | 159 | 2 | IPR011704 | |
| Domain | TUDOR | 6.13e-03 | 14 | 159 | 2 | PF00567 | |
| Domain | AAA_8 | 6.13e-03 | 14 | 159 | 2 | PF12780 | |
| Domain | AAA_5 | 6.13e-03 | 14 | 159 | 2 | PF07728 | |
| Domain | - | 6.31e-03 | 321 | 159 | 8 | 3.80.10.10 | |
| Domain | DHC_fam | 7.03e-03 | 15 | 159 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 7.03e-03 | 15 | 159 | 2 | PF03028 | |
| Domain | IBN_N | 7.03e-03 | 15 | 159 | 2 | PF03810 | |
| Domain | Dynein_heavy_dom | 7.03e-03 | 15 | 159 | 2 | IPR004273 | |
| Domain | L_dom-like | 7.15e-03 | 328 | 159 | 8 | IPR032675 | |
| Domain | HEAT | 7.91e-03 | 48 | 159 | 3 | PF02985 | |
| Domain | IBN_N | 7.99e-03 | 16 | 159 | 2 | SM00913 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 2.16e-08 | 5 | 116 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 2.94e-06 | 13 | 116 | 4 | M18256 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | NDST1 CYP11A1 CYP27B1 NDST4 NDST3 SULT1A2 SULT1A4 SULT1A1 SULT1A3 | 4.68e-06 | 153 | 116 | 9 | MM15844 |
| Pathway | WP_ESTROGEN_METABOLISM | 2.84e-05 | 22 | 116 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 3.42e-05 | 23 | 116 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.07e-05 | 24 | 116 | 4 | M16289 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 8.54e-05 | 11 | 116 | 3 | M47921 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.33e-04 | 183 | 116 | 8 | M39588 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.87e-04 | 39 | 116 | 4 | MM15695 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 3.39e-04 | 17 | 116 | 3 | M39483 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 3.49e-04 | 41 | 116 | 4 | M48095 | |
| Pathway | WP_RETINOL_METABOLISM | 4.58e-04 | 44 | 116 | 4 | MM15851 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 5.39e-04 | 81 | 116 | 5 | M748 | |
| Pubmed | 5.01e-11 | 7 | 167 | 5 | 12438748 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 24318996 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 33414449 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 5.13e-10 | 4 | 167 | 4 | 12390022 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8424956 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 8288252 | ||
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 25370010 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 1.85e-09 | 12 | 167 | 5 | 7706460 | |
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 11389699 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 29908303 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 25053625 | ||
| Pubmed | 2.55e-09 | 5 | 167 | 4 | 24802129 | ||
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 9370299 | ||
| Pubmed | ELOA MYH3 MACC1 CUX2 SYNE1 ABCB5 CNTRL RSF1 ODF2 LYST CYFIP2 CREBRF ACSL3 SYNE2 CEP83 PKHD1 KDR ATP11A GPR171 USP1 ATP2A3 DNAH8 PREX1 RPL4 MYBPC1 | 2.83e-08 | 1442 | 167 | 25 | 35575683 | |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 3.54e-08 | 8 | 167 | 4 | 10594240 | |
| Pubmed | 4.60e-08 | 21 | 167 | 5 | 32301970 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 6.34e-08 | 9 | 167 | 4 | 23207770 | |
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 19548878 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 9177785 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 9166597 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 6.34e-08 | 9 | 167 | 4 | 9060415 | |
| Pubmed | 1.05e-07 | 10 | 167 | 4 | 7601475 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 1.09e-07 | 3 | 167 | 3 | 8363592 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 9855620 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 8912648 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 1.65e-07 | 11 | 167 | 4 | 7613026 | |
| Pubmed | 1.65e-07 | 11 | 167 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.65e-07 | 11 | 167 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.65e-07 | 11 | 167 | 4 | 9034160 | |
| Pubmed | 1.65e-07 | 11 | 167 | 4 | 10720750 | ||
| Pubmed | 3.54e-07 | 13 | 167 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 3.54e-07 | 13 | 167 | 4 | 17425406 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 NDST1 GBF1 DOCK9 RTTN LAMA5 DDX56 TSC2 LYST FOCAD KMT2D XPO6 FANCI CLN3 XXYLT1 PYGB HERC1 DNMBP ATP2A3 PREX1 | 4.01e-07 | 1105 | 167 | 20 | 35748872 |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 22049073 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 32152050 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 12070138 | ||
| Pubmed | MON2 ELOA NRDC COPB1 MRPL37 DDX56 ACSL3 NAMPT NCAPG IPO9 ELMO2 FANCI PYGB MED23 | 6.06e-07 | 560 | 167 | 14 | 35241646 | |
| Pubmed | 6.72e-07 | 15 | 167 | 4 | 1741163 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 11087757 | ||
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 20056724 | ||
| Pubmed | 1.56e-06 | 225 | 167 | 9 | 12168954 | ||
| Pubmed | 5.98e-06 | 8 | 167 | 3 | 24067353 | ||
| Pubmed | 1.06e-05 | 216 | 167 | 8 | 31519766 | ||
| Pubmed | 1.06e-05 | 285 | 167 | 9 | 32838362 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 1.27e-05 | 10 | 167 | 3 | 11535246 | |
| Pubmed | MON2 ELOA NOP53 CCDC18 ODF2 SLC30A1 CYFIP2 ACSL3 KMT2D NCAPG IPO9 FANCI SYNE2 CCDC138 HERC1 USP1 MPP7 | 1.33e-05 | 1049 | 167 | 17 | 27880917 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 1.74e-05 | 11 | 167 | 3 | 15944372 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 SAMD4B CCDC18 TSC2 ALPK1 TTK LYST IPO9 ELMO2 SYNE2 CCDC138 GAN DNMBP ARAP2 SAMD4A | 1.91e-05 | 861 | 167 | 15 | 36931259 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NDST1 WARS1 SLC35A1 LAMA5 GXYLT1 TSC2 H6PD SLC30A1 HNRNPK TMTC3 XPO6 FANCI XXYLT1 UTP20 CHSY3 TMEM41B ATP2A3 TANGO6 | 2.07e-05 | 1201 | 167 | 18 | 35696571 |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18559600 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 2.29e-05 | 2 | 167 | 2 | 14871892 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 19330019 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.29e-05 | 2 | 167 | 2 | 24931616 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 2.29e-05 | 2 | 167 | 2 | 38069221 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11207031 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 2.29e-05 | 2 | 167 | 2 | 20936502 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 29705271 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20417180 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 2.29e-05 | 2 | 167 | 2 | 10762004 | |
| Pubmed | STAT4 is a target of the hematopoietic zinc-finger transcription factor Ikaros in T cells. | 2.29e-05 | 2 | 167 | 2 | 16081070 | |
| Pubmed | Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. | 2.29e-05 | 2 | 167 | 2 | 17470635 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 10617600 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 14656762 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22768332 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22321252 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 2.29e-05 | 2 | 167 | 2 | 23358261 | |
| Pubmed | Mammalian Smaug is a translational repressor that forms cytoplasmic foci similar to stress granules. | 2.29e-05 | 2 | 167 | 2 | 16221671 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.29e-05 | 2 | 167 | 2 | 17267447 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 10543947 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.29e-05 | 2 | 167 | 2 | 24718612 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24586179 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 2.29e-05 | 2 | 167 | 2 | 7581483 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15752422 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17761684 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 2.29e-05 | 2 | 167 | 2 | 8117269 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31578382 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 9566757 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 30169771 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8093002 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 12469224 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 31145702 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16133548 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8033246 | ||
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 2.32e-05 | 12 | 167 | 3 | 19915574 | |
| Pubmed | 2.32e-05 | 12 | 167 | 3 | 12460940 | ||
| Pubmed | DOCK2 SH3TC2 GBF1 ALPK1 WDFY4 IPO9 ATP11A N4BP1 TMEM41B PREX1 TANGO6 | 2.88e-05 | 493 | 167 | 11 | 15368895 | |
| Pubmed | 3.11e-05 | 251 | 167 | 8 | 29778605 | ||
| Pubmed | MON2 COPB1 MRPL37 TSC2 TTK RSU1 ACSL3 DNAAF5 BBS7 FANCI DHX32 UQCRFS1 | 3.98e-05 | 606 | 167 | 12 | 36538041 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 WARS1 NRDC COPB1 NOP53 SYNE1 MRPL37 DDX56 HNRNPK CYFIP2 ACSL3 NAMPT NCAPG IPO9 FANCI UTP20 MED23 RPL4 MYBPC1 | 5.90e-05 | 1425 | 167 | 19 | 30948266 |
| Pubmed | GBF1 SAMD4B TSC2 RSU1 CYFIP2 LRCH3 ACSL3 CCDC138 MPP7 SAMD4A | 6.42e-05 | 446 | 167 | 10 | 24255178 | |
| Pubmed | 6.46e-05 | 87 | 167 | 5 | 12465718 | ||
| Pubmed | MON2 COPB1 DCTN2 NOP53 DDX56 TSC2 LRCH3 EHD2 ACSL3 DNAAF5 NAMPT NCAPG IPO9 FANCI SYNE2 DHX32 VTI1B SAMD4A RBM17 | 6.77e-05 | 1440 | 167 | 19 | 30833792 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 7695643 | ||
| Pubmed | MZT Proteins Form Multi-Faceted Structural Modules in the Ī³-Tubulin Ring Complex. | 6.85e-05 | 3 | 167 | 2 | 32610146 | |
| Pubmed | 6.85e-05 | 3 | 167 | 2 | 18259693 | ||
| Interaction | GPR182 interactions | MON2 GBF1 TSC2 INTS8 TTK CYFIP2 FOCAD DNAAF5 XPO6 FANCI CCDC138 UTP20 MED23 MZT2B ATP2A3 | 3.62e-06 | 455 | 160 | 15 | int:GPR182 |
| Interaction | OPALIN interactions | 6.83e-06 | 209 | 160 | 10 | int:OPALIN | |
| Interaction | CHRM4 interactions | 1.00e-05 | 94 | 160 | 7 | int:CHRM4 | |
| Interaction | SULT1C2 interactions | 1.35e-05 | 19 | 160 | 4 | int:SULT1C2 | |
| Interaction | NPY2R interactions | 1.40e-05 | 66 | 160 | 6 | int:NPY2R | |
| Interaction | GPR17 interactions | GBF1 TSC2 TTK DNAAF5 NCAPG XPO6 UTP20 ALG8 MED23 MZT2B ATP2A3 | 1.68e-05 | 283 | 160 | 11 | int:GPR17 |
| Interaction | NDST4 interactions | 2.67e-05 | 8 | 160 | 3 | int:NDST4 | |
| Interaction | BTNL9 interactions | 3.55e-05 | 156 | 160 | 8 | int:BTNL9 | |
| Interaction | SULT1A3 interactions | 3.59e-05 | 24 | 160 | 4 | int:SULT1A3 | |
| Interaction | RAC1 interactions | DOCK2 GBF1 DOCK9 DDX56 SLC30A1 RSU1 HNRNPK CYFIP2 LRCH3 EHD2 ACSL3 TMTC3 ELMO2 HPS4 TLR2 UTP20 ATP11A DNMBP PREX1 MPP7 ARAP2 VTI1B | 3.60e-05 | 1063 | 160 | 22 | int:RAC1 |
| Interaction | NDST3 interactions | 3.98e-05 | 9 | 160 | 3 | int:NDST3 | |
| Cytoband | 16p12.1 | 1.03e-04 | 25 | 167 | 3 | 16p12.1 | |
| Cytoband | 12q14.1 | 1.45e-04 | 28 | 167 | 3 | 12q14.1 | |
| Cytoband | 3q29 | 2.48e-04 | 83 | 167 | 4 | 3q29 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.28e-06 | 14 | 111 | 4 | 762 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.22e-04 | 4 | 111 | 2 | 1252 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.31e-03 | 9 | 111 | 2 | 1230 | |
| GeneFamily | Glycosyltransferase family 8 | 1.31e-03 | 9 | 111 | 2 | 436 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.50e-03 | 37 | 111 | 3 | 763 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 NRDC COPB1 NOP53 SYNE1 DOCK9 CNTRL RSF1 IKZF1 JAML LYST STAT4 CYFIP2 PCED1B CREBRF KMT2D TRANK1 ELMO2 XPO6 DZIP3 N4BP1 GPR171 HERC1 USP1 PREX1 RPL4 ARAP2 | 6.94e-07 | 1492 | 165 | 27 | M40023 |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 4.84e-06 | 198 | 165 | 9 | M3171 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | DOCK2 NOP53 SYNE1 CNTRL IKZF1 JAML RSU1 HNRNPK STAT4 CYFIP2 PCED1B XPO6 SYNE2 GPR171 HERC1 ATP2A3 PREX1 RPL4 ARAP2 | 5.06e-06 | 911 | 165 | 19 | M40038 |
| Coexpression | AIZARANI_LIVER_C23_KUPFFER_CELLS_3 | 1.17e-05 | 221 | 165 | 9 | M39124 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 1.46e-05 | 24 | 165 | 4 | MM1317 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | SH3TC2 SYNE1 DOCK9 H6PD WDFY4 PKHD1L1 SLC39A8 PCED1B SULT1A2 SULT1A4 SULT1A1 SULT1A3 KDR | 1.50e-05 | 491 | 165 | 13 | MM455 |
| Coexpression | GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN | 3.84e-05 | 198 | 165 | 8 | M5507 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_UP | 4.12e-05 | 200 | 165 | 8 | M4490 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 5.18e-05 | 267 | 165 | 9 | M41130 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | GBF1 NRDC SYNE1 DOCK9 TSC2 EHD2 PRUNE1 SULT1A2 NCAPG TRANK1 XPO6 HPS4 SYNE2 | 6.59e-05 | 567 | 165 | 13 | M16909 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-09 | 187 | 167 | 10 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-08 | 195 | 167 | 9 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.34e-08 | 198 | 167 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.62e-08 | 199 | 167 | 9 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-07 | 168 | 167 | 8 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-07 | 182 | 167 | 8 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-07 | 182 | 167 | 8 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.69e-07 | 183 | 167 | 8 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.69e-07 | 183 | 167 | 8 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 6.23e-07 | 190 | 167 | 8 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.01e-07 | 193 | 167 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 7.58e-07 | 195 | 167 | 8 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 195 | 167 | 8 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.88e-07 | 196 | 167 | 8 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.88e-07 | 196 | 167 | 8 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.18e-07 | 197 | 167 | 8 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.18e-07 | 197 | 167 | 8 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.18e-07 | 197 | 167 | 8 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-07 | 197 | 167 | 8 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-07 | 197 | 167 | 8 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | Severe-Lymphoid-T-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 8.18e-07 | 197 | 167 | 8 | 0489e0b08f3c3ef90b166ea2f26a0b2b12bd2077 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-07 | 197 | 167 | 8 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 8.18e-07 | 197 | 167 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-07 | 197 | 167 | 8 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.50e-07 | 198 | 167 | 8 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-07 | 199 | 167 | 8 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.83e-07 | 199 | 167 | 8 | 4669b6be3b513d80b6f79bd10a1974fefdf58093 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | d8459e45a8396a9ee063666a1928c649162c5727 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | dbbc7e16929e744b48017da068479a6046e99cf6 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | 13d8c5d65d7f900979319433e7044efa6d06de20 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 156 | 167 | 7 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 159 | 167 | 7 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 159 | 167 | 7 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 169 | 167 | 7 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 173 | 167 | 7 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-06 | 173 | 167 | 7 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-06 | 173 | 167 | 7 | 70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-06 | 176 | 167 | 7 | 8488997e0f02e874f53fae1690da63e0dd1d0780 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-06 | 178 | 167 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.59e-06 | 118 | 167 | 6 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.59e-06 | 118 | 167 | 6 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | Severe-Lymphoid-T-innate_T|Severe / Condition, Lineage, Cell class and cell subclass | 5.59e-06 | 181 | 167 | 7 | 50ab8562552339d97e4f19aa6ae49fd797da492e | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 5.59e-06 | 181 | 167 | 7 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.80e-06 | 182 | 167 | 7 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-06 | 119 | 167 | 6 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| ToppCell | Control-Lymphoid_T/NK-NK_activated|Control / Disease group, lineage and cell class | 5.86e-06 | 119 | 167 | 6 | a258d91ac90d4174b6f203d7f96ba6e57c6003e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-06 | 119 | 167 | 6 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 183 | 167 | 7 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.01e-06 | 183 | 167 | 7 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-06 | 184 | 167 | 7 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 186 | 167 | 7 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 6.92e-06 | 187 | 167 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 187 | 167 | 7 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.17e-06 | 188 | 167 | 7 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-06 | 188 | 167 | 7 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-06 | 188 | 167 | 7 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.17e-06 | 188 | 167 | 7 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-06 | 188 | 167 | 7 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | ba61f04fd38efae01f721ba616252d1372ff1002 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.68e-06 | 190 | 167 | 7 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-06 | 190 | 167 | 7 | 5a37568000dfc33fcbb59b578c1963fb7cf872ec | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.95e-06 | 191 | 167 | 7 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.95e-06 | 191 | 167 | 7 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.95e-06 | 191 | 167 | 7 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 167 | 7 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 167 | 7 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.95e-06 | 191 | 167 | 7 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 167 | 7 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 8.22e-06 | 192 | 167 | 7 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.22e-06 | 192 | 167 | 7 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.50e-06 | 193 | 167 | 7 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.50e-06 | 193 | 167 | 7 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 8.50e-06 | 193 | 167 | 7 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.80e-06 | 194 | 167 | 7 | b191851b2287afc8c47320f5488fd22e2a454aa6 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 8.80e-06 | 194 | 167 | 7 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 8.80e-06 | 194 | 167 | 7 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 8.80e-06 | 194 | 167 | 7 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 8.80e-06 | 194 | 167 | 7 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-06 | 194 | 167 | 7 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.80e-06 | 194 | 167 | 7 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.80e-06 | 194 | 167 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.09e-06 | 195 | 167 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 9.09e-06 | 195 | 167 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 9.09e-06 | 195 | 167 | 7 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 195 | 167 | 7 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-06 | 195 | 167 | 7 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.40e-06 | 196 | 167 | 7 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.40e-06 | 196 | 167 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-06 | 197 | 167 | 7 | 04aaf35ef4db6325b2b2b92e93272f1973764b78 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.72e-06 | 197 | 167 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Severe-Lymphoid-T-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.72e-06 | 197 | 167 | 7 | 00d884ec591f63a345d7fd0a6b368f9da4b4c6ce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 197 | 167 | 7 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| Drug | dopamine-4-O-sulfate | 9.15e-08 | 7 | 165 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 9.15e-08 | 7 | 165 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 9.15e-08 | 7 | 165 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 9.15e-08 | 7 | 165 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 1.82e-07 | 8 | 165 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 1.82e-07 | 8 | 165 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 1.82e-07 | 8 | 165 | 4 | CID000010784 | |
| Drug | minoxidil sulphate | 8.89e-07 | 25 | 165 | 5 | CID000004202 | |
| Drug | 4-octylphenol | 1.11e-06 | 47 | 165 | 6 | CID000015730 | |
| Drug | EM-139 | 1.81e-06 | 13 | 165 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 2.52e-06 | 14 | 165 | 4 | CID000020908 | |
| Drug | deoxoestrone | 2.52e-06 | 14 | 165 | 4 | CID000005888 | |
| Drug | arylsulfate | 3.41e-06 | 15 | 165 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 3.41e-06 | 15 | 165 | 4 | CID000002895 | |
| Drug | A-44 | 4.52e-06 | 16 | 165 | 4 | CID000120353 | |
| Drug | acridone | 5.88e-06 | 17 | 165 | 4 | CID000002015 | |
| Drug | benzilic acid | 5.88e-06 | 17 | 165 | 4 | CID000006463 | |
| Drug | phenylhydroxylamine | 7.78e-06 | 38 | 165 | 5 | CID000007518 | |
| Drug | AC1Q6OHG | 9.47e-06 | 19 | 165 | 4 | CID000115063 | |
| Drug | pedunculagin | 9.47e-06 | 19 | 165 | 4 | CID000442688 | |
| Drug | d-equilenin | 1.14e-05 | 41 | 165 | 5 | CID000010597 | |
| Drug | PLP-Glu | 1.18e-05 | 20 | 165 | 4 | CID000444293 | |
| Drug | Phosphoadenosine Phosphosulfate | 1.28e-05 | 7 | 165 | 3 | ctd:D010724 | |
| Drug | Pyrethroids | 1.28e-05 | 71 | 165 | 6 | CID000005053 | |
| Drug | N-hydroxy-2-aminofluorene | 1.45e-05 | 21 | 165 | 4 | CID000005895 | |
| Drug | MeA alpha C | 1.76e-05 | 22 | 165 | 4 | CID000062244 | |
| Drug | AABSSN | 1.76e-05 | 22 | 165 | 4 | CID005464134 | |
| Drug | N-hydroxy-4-aminobiphenyl | 2.04e-05 | 8 | 165 | 3 | ctd:C014593 | |
| Drug | taselin | 2.11e-05 | 23 | 165 | 4 | CID000023846 | |
| Drug | 4-hydroxyestradiol | 2.37e-05 | 79 | 165 | 6 | CID000001743 | |
| Drug | sulfamethazine | 2.50e-05 | 48 | 165 | 5 | CID000005327 | |
| Drug | AalphaC | 2.52e-05 | 24 | 165 | 4 | CID000062805 | |
| Drug | reverse T3 | 2.94e-05 | 82 | 165 | 6 | CID000022069 | |
| Drug | AzMC | 2.99e-05 | 25 | 165 | 4 | CID000064986 | |
| Drug | 2-pentanone | 2.99e-05 | 25 | 165 | 4 | CID000007895 | |
| Drug | alpha-methyldopamine | 3.51e-05 | 26 | 165 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 3.51e-05 | 26 | 165 | 4 | CID000115245 | |
| Drug | 1m2q | 3.51e-05 | 26 | 165 | 4 | CID005326637 | |
| Drug | androstenediol | 4.47e-05 | 54 | 165 | 5 | CID000010634 | |
| Drug | AC1Q6OQF | 4.88e-05 | 55 | 165 | 5 | CID000009685 | |
| Drug | Hydroxytryptophol | 5.22e-05 | 2 | 165 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 5.22e-05 | 2 | 165 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 5.22e-05 | 2 | 165 | 2 | ctd:C012365 | |
| Drug | Glu-P-2 | 5.48e-05 | 29 | 165 | 4 | CID000049970 | |
| Drug | 3,3'-T2 | 6.29e-05 | 30 | 165 | 4 | CID000065559 | |
| Drug | NSC36919 | 6.32e-05 | 58 | 165 | 5 | CID000235496 | |
| Drug | A2'p5'A2'p5'A | 7.18e-05 | 31 | 165 | 4 | CID000122642 | |
| Drug | barium hydroxide | 7.18e-05 | 31 | 165 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 7.18e-05 | 31 | 165 | 4 | CID000083939 | |
| Drug | 2-aminoacetophenone | 7.84e-05 | 12 | 165 | 3 | CID000011952 | |
| Drug | adenosine 3'-5'-diphosphate | 8.03e-05 | 98 | 165 | 6 | CID000000073 | |
| Drug | DCNP | 9.24e-05 | 33 | 165 | 4 | CID000012066 | |
| Drug | 3-OHBaP | 9.42e-05 | 63 | 165 | 5 | CID000025890 | |
| Drug | 4-nonylphenol | 1.02e-04 | 64 | 165 | 5 | CID000001752 | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; HL60; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 2994_UP | |
| Drug | A21250 | 1.18e-04 | 105 | 165 | 6 | CID000000990 | |
| Drug | n-butyl acetate | 1.28e-04 | 14 | 165 | 3 | CID000031272 | |
| Drug | 5-iodouracil | 1.31e-04 | 36 | 165 | 4 | CID000069672 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 1.34e-04 | 206 | 165 | 8 | CID000005645 | |
| Drug | mefenamic acid | 1.46e-04 | 37 | 165 | 4 | CID000004044 | |
| Drug | 8-azaadenine | 1.56e-04 | 3 | 165 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.56e-04 | 3 | 165 | 2 | ctd:C030629 | |
| Drug | 2-hexadecyne | 1.56e-04 | 3 | 165 | 2 | CID014009124 | |
| Drug | 5-hydroxy-3-methylindole | 1.56e-04 | 3 | 165 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.56e-04 | 3 | 165 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.56e-04 | 3 | 165 | 2 | ctd:D008914 | |
| Drug | 3,5-diiodo-L-thyronine | 1.62e-04 | 38 | 165 | 4 | CID000092859 | |
| Drug | adenylylsulfate | 1.78e-04 | 72 | 165 | 5 | CID000000228 | |
| Drug | estrone sulfate | 1.91e-04 | 163 | 165 | 7 | CID000000699 | |
| Drug | vitamin D3 | 1.97e-04 | 277 | 165 | 9 | CID000002735 | |
| Disease | platelet component distribution width | SH3TC2 ATP23 SYNE1 DOCK9 RTTN LAMA5 IKZF1 SLC30A1 RSU1 SLC39A8 HNRNPK ACSL3 FAM187B TRANK1 CLN3 PYGB HERC1 PREX1 MYBPC1 | 2.85e-08 | 755 | 159 | 19 | EFO_0007984 |
| Disease | Drug habituation | 3.11e-06 | 115 | 159 | 7 | C0013170 | |
| Disease | Drug abuse | 3.11e-06 | 115 | 159 | 7 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.11e-06 | 115 | 159 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 3.11e-06 | 115 | 159 | 7 | C0236969 | |
| Disease | Drug Use Disorders | 3.11e-06 | 115 | 159 | 7 | C0013222 | |
| Disease | Drug Dependence | 3.11e-06 | 115 | 159 | 7 | C1510472 | |
| Disease | Substance Dependence | 3.11e-06 | 115 | 159 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 3.11e-06 | 115 | 159 | 7 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.11e-06 | 115 | 159 | 7 | C0029231 | |
| Disease | Substance abuse problem | 3.29e-06 | 116 | 159 | 7 | C0740858 | |
| Disease | azoospermia (implicated_via_orthology) | 1.29e-05 | 27 | 159 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | nuclear protein localization protein 4 homolog measurement | 2.89e-05 | 2 | 159 | 2 | EFO_0801851 | |
| Disease | Thyroid Hypoplasia | 8.63e-05 | 3 | 159 | 2 | C0151516 | |
| Disease | mean arterial pressure | SH3TC2 CUX2 WARS1 ESRRB SLC39A8 ULK3 YEATS2 SLC34A1 PKHD1 PREX1 RBM17 | 8.86e-05 | 499 | 159 | 11 | EFO_0006340 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.72e-04 | 4 | 159 | 2 | cv:CN293514 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.72e-04 | 4 | 159 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.85e-04 | 5 | 159 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.85e-04 | 5 | 159 | 2 | C0410190 | |
| Disease | Thyroid Agenesis | 2.85e-04 | 5 | 159 | 2 | C0749420 | |
| Disease | airway responsiveness measurement | 2.86e-04 | 24 | 159 | 3 | EFO_0006897 | |
| Disease | maximal oxygen uptake measurement | 3.64e-04 | 26 | 159 | 3 | EFO_0004887 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.27e-04 | 6 | 159 | 2 | cv:C0410189 | |
| Disease | cyclic AMP-dependent transcription factor ATF-6 alpha measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0801505 | |
| Disease | Digitotalar Dysmorphism | 4.27e-04 | 6 | 159 | 2 | C1852085 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.27e-04 | 6 | 159 | 2 | C0410189 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 4.27e-04 | 6 | 159 | 2 | C0220662 | |
| Disease | Colorectal Carcinoma | AKAP6 SYNE1 ABCB5 SLCO1B3 TYMP NDST3 NAMPT NCAPG TLR2 PKHD1 KDR DNAH8 | 4.44e-04 | 702 | 159 | 12 | C0009402 |
| Disease | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0802332 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.95e-04 | 7 | 159 | 2 | C0751337 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 7.33e-04 | 75 | 159 | 4 | EFO_0007006, EFO_0009262 | |
| Disease | verbal-numerical reasoning measurement | 7.35e-04 | 131 | 159 | 5 | EFO_0008394 | |
| Disease | Colorectal Neoplasms | 7.90e-04 | 277 | 159 | 7 | C0009404 | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 7.91e-04 | 8 | 159 | 2 | EFO_0801971 | |
| Disease | female breast cancer (is_implicated_in) | 7.91e-04 | 8 | 159 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | mean corpuscular hemoglobin concentration | CUX2 RTTN IKZF1 TSC2 TSHR TYMP SLC30A1 INTS8 FOCAD SLC34A1 BBS7 MAST1 DHX32 USP1 PREX1 | 9.71e-04 | 1105 | 159 | 15 | EFO_0004528 |
| Disease | Distal arthrogryposis | 1.01e-03 | 9 | 159 | 2 | cv:C0265213 | |
| Disease | protein FAM163B measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0802936 | |
| Disease | X-21467 measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0020007 | |
| Disease | Seizures | 1.21e-03 | 218 | 159 | 6 | C0036572 | |
| Disease | visceral adipose tissue measurement | 1.24e-03 | 481 | 159 | 9 | EFO_0004765 | |
| Disease | cholesteatoma (is_marker_for) | 1.26e-03 | 10 | 159 | 2 | DOID:869 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.43e-03 | 152 | 159 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease | 1.51e-03 | 42 | 159 | 3 | cv:C0007959 | |
| Disease | diffuse scleroderma (is_implicated_in) | 1.54e-03 | 11 | 159 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.54e-03 | 11 | 159 | 2 | EFO_0021862 | |
| Disease | prostate cancer (is_marker_for) | 1.60e-03 | 156 | 159 | 5 | DOID:10283 (is_marker_for) | |
| Disease | psoriasis (is_marker_for) | 1.73e-03 | 44 | 159 | 3 | DOID:8893 (is_marker_for) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.84e-03 | 12 | 159 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | X-12707 measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0800720 | |
| Disease | urate measurement, bone density | 2.01e-03 | 619 | 159 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | Malignant neoplasm of breast | AKAP6 WARS1 SYNE1 H6PD HNRNPK STAT4 KMT2D SULT1A1 UNC45B SYNE2 UTP20 KDR DHX32 ATP2A3 | 2.08e-03 | 1074 | 159 | 14 | C0006142 |
| Disease | X-24588 measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800898 | |
| Disease | colon carcinoma (is_marker_for) | 2.16e-03 | 13 | 159 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Hypercalcemia | 2.16e-03 | 13 | 159 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 2.16e-03 | 13 | 159 | 2 | C0026141 | |
| Disease | Generalized seizures | 2.21e-03 | 101 | 159 | 4 | C0234533 | |
| Disease | Clonic Seizures | 2.21e-03 | 101 | 159 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 2.21e-03 | 101 | 159 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 2.21e-03 | 101 | 159 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 2.21e-03 | 101 | 159 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.21e-03 | 101 | 159 | 4 | C0751123 | |
| Disease | Complex partial seizures | 2.21e-03 | 101 | 159 | 4 | C0149958 | |
| Disease | Single Seizure | 2.21e-03 | 101 | 159 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 2.21e-03 | 101 | 159 | 4 | C3495874 | |
| Disease | Visual seizure | 2.21e-03 | 101 | 159 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 2.21e-03 | 101 | 159 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 2.21e-03 | 101 | 159 | 4 | C0422855 | |
| Disease | Gustatory seizure | 2.21e-03 | 101 | 159 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.21e-03 | 101 | 159 | 4 | C0422850 | |
| Disease | Olfactory seizure | 2.21e-03 | 101 | 159 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 2.21e-03 | 101 | 159 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.21e-03 | 101 | 159 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 2.21e-03 | 101 | 159 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 2.21e-03 | 101 | 159 | 4 | C4317109 | |
| Disease | Absence Seizures | 2.29e-03 | 102 | 159 | 4 | C4316903 | |
| Disease | Convulsions | 2.29e-03 | 102 | 159 | 4 | C4048158 | |
| Disease | Tonic Seizures | 2.29e-03 | 102 | 159 | 4 | C0270844 | |
| Disease | Seizures, Focal | 2.46e-03 | 104 | 159 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 2.46e-03 | 104 | 159 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.46e-03 | 104 | 159 | 4 | C0494475 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.52e-03 | 14 | 159 | 2 | EFO_0800173 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.89e-03 | 15 | 159 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.89e-03 | 15 | 159 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | health literacy measurement | 2.95e-03 | 53 | 159 | 3 | EFO_0010104 | |
| Disease | interleukin 1 receptor antagonist measurement | 2.95e-03 | 53 | 159 | 3 | EFO_0004754 | |
| Disease | red blood cell density measurement | IKZF1 SLC39A8 FOCAD FRMD4A TMTC3 SULT1A1 SLC34A1 XXYLT1 PKHD1 ATP11A USP1 PREX1 | 3.01e-03 | 880 | 159 | 12 | EFO_0007978 |
| Disease | alcohol consumption measurement | AKAP6 CUX2 CYP11A1 ALPK1 SYT10 SLC39A8 NDST3 FRMD4A IPO9 SULT1A1 TTLL6 CLN3 PKHD1 ARAP2 TANGO6 | 3.01e-03 | 1242 | 159 | 15 | EFO_0007878 |
| Disease | Ciliopathies | 3.01e-03 | 110 | 159 | 4 | C4277690 | |
| Disease | Intellectual Disability | 3.03e-03 | 447 | 159 | 8 | C3714756 | |
| Disease | Chromosome Aberrations | 3.29e-03 | 16 | 159 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 3.29e-03 | 16 | 159 | 2 | C0004403 | |
| Disease | theta wave measurement | 3.72e-03 | 17 | 159 | 2 | EFO_0006873 | |
| Disease | X-21441 measurement | 3.72e-03 | 17 | 159 | 2 | EFO_0800814 | |
| Disease | blood osmolality measurement | 3.81e-03 | 58 | 159 | 3 | EFO_0007967 | |
| Disease | atrial fibrillation | 4.10e-03 | 371 | 159 | 7 | EFO_0000275 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.17e-03 | 18 | 159 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Bipolar Disorder | 4.47e-03 | 477 | 159 | 8 | C0005586 | |
| Disease | kidney failure (biomarker_via_orthology) | 4.65e-03 | 19 | 159 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.07e-03 | 291 | 159 | 6 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPAVVKSELKDLLAL | 131 | Q8NAT2 | |
| KSELKDLLALSPVLL | 136 | Q8NAT2 | |
| LPFSLVGILEINKKI | 196 | Q5H9S7 | |
| GTNVKTKVPLLLEIL | 686 | Q8IWZ6 | |
| PLSDKLLRKVIQVEL | 41 | Q9Y4X3 | |
| ISKLKPLQDLISLIL | 211 | Q7Z7A1 | |
| IVSSKKITRPLLLLN | 121 | Q96FN4 | |
| LPESIKENTLLKLRI | 381 | Q9BXY5 | |
| AKRIIISLKINDPLV | 141 | Q32M84 | |
| QLKDLLPEHLKLTTL | 66 | Q9C0J9 | |
| EELAPKIKILLLQSV | 111 | H3BNL8 | |
| QKLEILIKDTLGLPV | 591 | Q8IUR6 | |
| LPEEFALVLTLLLKK | 96 | Q07092 | |
| ISLPEVSLLKILKLN | 671 | Q2M3G0 | |
| IARALLQKPKILLLD | 1166 | Q2M3G0 | |
| LILKLPVIFAKIQLE | 331 | Q9NZN4 | |
| LLAQLTKPSLTQKEI | 1201 | A8K2U0 | |
| QALEQLKPLLSLLKV | 1196 | Q6XZF7 | |
| LTNDILAIKNIIPTK | 1356 | Q8WZ64 | |
| KLQILTPQKLELLRA | 106 | Q9Y592 | |
| EKLTPVLLAKQLAAL | 131 | Q13561 | |
| LKDVLLARPELKLII | 201 | Q7L7V1 | |
| LKLIINSSPHLISKL | 211 | Q7L7V1 | |
| QDLSLLQIKKPRVVL | 1161 | O14529 | |
| LQISLPVILLDEALK | 971 | Q93084 | |
| IPSTILLILEDKTIK | 1111 | Q96QP1 | |
| AASLVPKAKIITILI | 681 | O95803 | |
| ELLSFIKKLREPLVL | 756 | Q75QN2 | |
| IKKLREPLVLTIILS | 761 | Q75QN2 | |
| LNPLKSIVEKSILLT | 81 | Q9GZZ8 | |
| SKNLKLVPLQVLICS | 316 | Q6ZNQ3 | |
| ATVLSQLPLLKAVVK | 361 | O15528 | |
| VSRKKLLPLLQEALS | 346 | Q86TP1 | |
| LLKTLETNPYVKLLL | 56 | Q9Y6H3 | |
| PIILTALATKKENLA | 131 | Q9NVI1 | |
| PLKVLIASNNKLVSL | 151 | Q96II8 | |
| LLKKPLRVDLILENT | 111 | Q9NZM5 | |
| PSKNLLLAEVINIIK | 386 | P80404 | |
| DKLSPKVVQSLLDLL | 1831 | Q15751 | |
| TKVEPLLLLKAARIL | 166 | Q9NQG7 | |
| ALKELILHNPVTLKL | 206 | Q9NY93 | |
| KDLVLLLQKDRLLTP | 31 | Q96HM7 | |
| VLPLQDHTIKKLLLV | 66 | P53618 | |
| TVLKEIAKTVLISLP | 721 | Q96JB1 | |
| PNVKKALINILLVTT | 216 | O14626 | |
| RSLLKPLELELQKTV | 396 | Q4G148 | |
| DLLKVILEKILTIPN | 136 | Q9ULK4 | |
| KPLNSEIRELLKLLS | 86 | Q5T2T1 | |
| ILLEITKDILNKLPS | 2816 | Q6ZR08 | |
| AALLPKAKVLTILIN | 691 | P52848 | |
| LEKTLPQLLAKLSIL | 2686 | O15230 | |
| ENLLLLSKAKLVPSE | 371 | Q13422 | |
| LQNIIKTLRVPLSLK | 1436 | Q7Z3U7 | |
| ASLVPKAKIITILID | 681 | Q9H3R1 | |
| ELLKIVKSLLQGTIL | 956 | Q96F07 | |
| GITLLNVSKLNILKL | 226 | P36578 | |
| TKLIEGLPEKVLSLV | 126 | Q9BZE1 | |
| KLQELALLLPIALKT | 81 | C9JSJ3 | |
| LLINDKVAQLPLSLK | 361 | O95502 | |
| VPVNLLLEVKKLLNA | 46 | Q86Y13 | |
| LLEVKKLLNAINTLP | 51 | Q86Y13 | |
| VTQLVKKLLIIISRP | 271 | Q9Y2H9 | |
| LLKIITEPFTKLIIQ | 266 | Q06495 | |
| VQPKLLAKELLDLVA | 36 | Q9P2Q2 | |
| AEKLLNNVISKLLPT | 81 | Q96DR5 | |
| LLRAPKLDLQILEKL | 586 | Q96M89 | |
| ILLPVITKELKELLE | 856 | Q92608 | |
| KLTPLSEISQRLLKL | 1821 | Q9BZ29 | |
| LLEIDQKRPLASIIK | 21 | Q96JJ3 | |
| LKKLSTLPITVDILA | 56 | Q14241 | |
| ELRSLEKIISQLPLK | 391 | Q5T9S5 | |
| LELSPQKLKEVISLE | 171 | Q9H2C0 | |
| LSAILPKELKRISLI | 366 | Q8IZF7 | |
| LQLVPLLKASIKETL | 371 | P05108 | |
| LEKSPCTKILLLGIL | 1366 | Q99698 | |
| TTRNLLEQIVLPLKK | 631 | Q6ZN28 | |
| DKTIILEQLRKISLP | 466 | O75899 | |
| IPLLVKILKLIINEL | 911 | Q96P70 | |
| KVLFPLLTKLLENIS | 1591 | Q92538 | |
| VKLIPVLQVKLSVLQ | 206 | Q63ZY3 | |
| VGNLLISILLVKDKT | 36 | P60893 | |
| LKGLKLVLLVVTVLA | 331 | Q17R55 | |
| ILSIKEFPLLLDIIK | 3691 | Q8NDH2 | |
| VSPEVFLKLILSTLK | 431 | Q86Y56 | |
| KLLLTLPLLRQTAAK | 391 | O95718 | |
| LSLPLINRAKKVAVL | 731 | O95479 | |
| TLALLKAQIDPVLLK | 201 | Q96T23 | |
| LSVLPLLAIKLSVLK | 181 | P0C7X4 | |
| KPILNLALKLLSVTE | 326 | Q5VW36 | |
| LALKLLSVTEDQKIP | 331 | Q5VW36 | |
| LKDLNLSLIPNKSLT | 76 | Q9BZA8 | |
| LQQLPDILKITEAKL | 596 | Q5BJF6 | |
| LTLAQLVEKRLLPLK | 541 | Q5VT03 | |
| TLELTRLLPLKFVKI | 116 | Q8TC56 | |
| ISLAVRKIALLLKPD | 26 | P82980 | |
| PDIGKLTKLQILSLR | 151 | Q15404 | |
| RPKIVQSLLSLLKLA | 226 | Q86VV8 | |
| LTGELKKALIEVLQP | 426 | P23381 | |
| TEVIKLLLSVGILAK | 51 | P78382 | |
| ILPLKEILQNTTSLK | 1981 | O75691 | |
| LLKDVKETLLSLLLP | 111 | B4DZS4 | |
| VKLLALLEVLSGQKL | 61 | Q8NF91 | |
| LQKPESVISVQKLLL | 5196 | Q8WXH0 | |
| LKKLTAEINQLTLVP | 926 | Q8NDG6 | |
| LATVLLKPLLKQPSE | 81 | A0AVI2 | |
| ILLLPVLILIVKKTC | 286 | Q86YT9 | |
| IKIILDLISESPIKG | 206 | P61978 | |
| IKIQILSKLRLETAP | 56 | O14793 | |
| KLVENILAKRLLILP | 616 | Q8TCU6 | |
| ELKLLIQAEFPSLLK | 31 | P29377 | |
| IQTALKSEEPLLALK | 1071 | Q8TF17 | |
| LSNKKPELIELLLIT | 291 | P11055 | |
| NPLDTVLKVLEILGK | 316 | P43490 | |
| LENPLEKEQKLLILL | 2816 | P08F94 | |
| LALLPQTLLDQKVKV | 111 | P0DMN0 | |
| LALLPQTLLDQKVKV | 111 | P0DMM9 | |
| EVLALKLENLTKLLP | 641 | Q13023 | |
| ELTEKPKFILSVLLL | 136 | Q9BVK2 | |
| IIFIPATILLKAKDI | 136 | Q08AH1 | |
| LLQTKLKDIVSLVPR | 216 | O95573 | |
| LLADILPTLVIKLLA | 101 | Q13286 | |
| LIPKQNVKLVIILFS | 646 | Q70JA7 | |
| KKLLAVLQEILILPT | 421 | Q9BPX3 | |
| LLTLKPRETSKNILI | 41 | Q8WZ69 | |
| LLVTISLLPDVLKKV | 1081 | P98196 | |
| VALLLQLLDTKKPEL | 181 | Q8IWX7 | |
| LFKKSLLLIPIHLEV | 631 | Q96HI0 | |
| VLALAKIEIKLSDIP | 146 | P47985 | |
| LALGKLLEPLQKSVL | 436 | O43511 | |
| KEKVVSLLLSHLPLL | 76 | Q5PRF9 | |
| LALLPQTLLDQKVKV | 111 | P50225 | |
| LALLPQTLLDQKVKV | 111 | P50226 | |
| PLVLKTLIQFTVKLR | 331 | Q14765 | |
| PALLQISKLKEVTLF | 271 | Q6ZV50 | |
| LTEILKCPTKVVLLR | 296 | Q96I25 | |
| ILLTVKIVQPELKAL | 556 | Q9NPD5 | |
| EFLTDLSQLKKLLPL | 511 | P11216 | |
| LSQLKKLLPLVSDEV | 516 | P11216 | |
| KLDLLKSLLRILVTP | 621 | Q6ZS81 | |
| LSPLKLTILANELKE | 531 | Q6P2S7 | |
| AVLKQLLPLLEKVSN | 716 | Q9C0B7 | |
| LIKPETLAKDVRLLI | 806 | O43847 | |
| IVHIIDKLLSPKNLL | 1716 | Q8WWQ8 | |
| ILLDQSTPILKMLLI | 2206 | Q86WI1 | |
| KPHLISELLTKLQLS | 721 | Q8N841 | |
| ELLVVKIIKALDLPA | 246 | Q6XYQ8 | |
| LKNTALKSIIALLVP | 226 | Q401N2 | |
| LSLLLKLEKNSVPLS | 66 | P33981 | |
| QITLPEQAKLLALVK | 426 | O94888 | |
| LASLLGLILTPLIKK | 141 | Q9C0K1 | |
| LPRLSIQKDILTIKA | 31 | P35968 | |
| ILAVLSILPAIFQKK | 271 | Q5BJD5 | |
| ITPLISTKVQDKLLL | 661 | Q96QU8 | |
| TAKELKALPILEELL | 716 | Q6ZXV5 | |
| LKESALILLQTVPKQ | 336 | Q9Y6M5 | |
| TSKQLLLLLDASLPK | 1201 | O15050 | |
| AAILILLEPIEKKAI | 731 | O60603 | |
| KVTTNKLLLSIIILL | 201 | Q9UEU0 | |
| LPLITASILSKKLVE | 211 | P19971 | |
| KDKVISLLLTHLPLL | 76 | Q9UPU9 | |
| KINTPLLTPLKLSLE | 551 | O94782 | |
| QQLLTAVVKKIPLIT | 1151 | Q9ULM3 | |
| KTAVLGLLVILQTKL | 561 | P49815 | |
| QNILLSSLEKPHLKL | 141 | Q6PHR2 | |
| PKEILQIIQLDLDLK | 216 | Q8NBI6 | |
| KPLITVSNSKILLVL | 651 | P16473 | |
| SVVLELLQALKLKSP | 2261 | Q9P2D8 | |
| KLKSPLPDTNLLLLV | 2271 | Q9P2D8 | |
| LLKQLKQELSLLPLT | 4551 | O14686 | |
| LLLKPCPETIKSLLI | 196 | Q9H6V9 | |
| ELLLNSLIRKKLLPE | 321 | P59046 | |
| SLIRKKLLPELSLLI | 326 | P59046 | |
| HSLLKKELVPLATLL | 346 | Q86W25 | |
| KELVPLATLLITIKT | 351 | Q86W25 | |
| FKILVDLLKLNVAPL | 56 | Q6P582 | |
| FKILVDLLKLNVAPL | 56 | Q6NZ67 | |
| LILPTSLKKELLTLT | 176 | O75113 | |
| LSVDLKPLKILTPLT | 426 | Q00872 |